These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11437103)

  • 1. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors.
    Yazawa K; Fujimori M; Nakamura T; Sasaki T; Amano J; Kano Y; Taniguchi S
    Breast Cancer Res Treat; 2001 Mar; 66(2):165-70. PubMed ID: 11437103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats.
    Sasaki T; Fujimori M; Hamaji Y; Hama Y; Ito K; Amano J; Taniguchi S
    Cancer Sci; 2006 Jul; 97(7):649-57. PubMed ID: 16827806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.
    Yazawa K; Fujimori M; Amano J; Kano Y; Taniguchi S
    Cancer Gene Ther; 2000 Feb; 7(2):269-74. PubMed ID: 10770636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients.
    Fujimori M
    Breast Cancer; 2006; 13(1):27-31. PubMed ID: 16518059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genus Bifidobacterium for cancer gene therapy.
    Fujimori M; Amano J; Taniguchi S
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Targeting Therapy Using Gene-Engineered Anaerobic-Nonpathogenic Bifidobacterium longum.
    Taniguchi S; Shimatani Y; Fujimori M
    Methods Mol Biol; 2016; 1409():49-60. PubMed ID: 26846801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anaerobic bacteria as a gene delivery system for breast cancer therapy].
    Fujimori M
    Nihon Rinsho; 2008 Jun; 66(6):1211-8. PubMed ID: 18540373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of Escherichia coli-Bifidobacterium longum shuttle vector and expression of tumor suppressor gene PTEN in B. longum].
    Hou X; Liu JE
    Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):347-52. PubMed ID: 16933599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy.
    Hidaka A; Hamaji Y; Sasaki T; Taniguchi S; Fujimori M
    Biosci Biotechnol Biochem; 2007 Dec; 71(12):2921-6. PubMed ID: 18159091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy.
    Xu YF; Zhu LP; Hu B; Fu GF; Zhang HY; Wang JJ; Xu GX
    Cancer Gene Ther; 2007 Feb; 14(2):151-7. PubMed ID: 17068487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis.
    Swanson SM; Unterman TG
    Carcinogenesis; 2002 Jun; 23(6):977-82. PubMed ID: 12082019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
    Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C
    Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of Bifidobacterium longum expressing α-melanocyte-stimulating hormone to combat ulcerative colitis.
    Wei P; Yang Y; Ding Q; Li X; Sun H; Liu Z; Huang J; Gong Y
    J Med Microbiol; 2016 Feb; 65(2):160-168. PubMed ID: 26567174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid induction of mammary cancer by repeated subcutaneous injection of the trans-3,4-dihydrodiol of 7,12-dimethylbenz[a]anthracene in the female Sprague-Dawley rat.
    Horn J; Lehner AF; Flesher JW
    Cancer Lett; 2005 Apr; 220(2):155-60. PubMed ID: 15766590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
    Reddy BS; Rivenson A
    Cancer Res; 1993 Sep; 53(17):3914-8. PubMed ID: 8358717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
    Fu GF; Li X; Hou YY; Fan YR; Liu WH; Xu GX
    Cancer Gene Ther; 2005 Feb; 12(2):133-40. PubMed ID: 15565182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat.
    Fiebig HH; Schmähl D
    Oncology; 1977; 34(2):58-61. PubMed ID: 408773
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors.
    Zhu LP; Yin Y; Xing J; Li C; Kou L; Hu B; Wu ZW; Wang JJ; Xu GX
    Cancer Sci; 2009 Oct; 100(10):1986-90. PubMed ID: 19678823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site of origin of mammary tumors induced by 7,12-dimethylbenz(a)anthracene in the rat.
    Sinha D; Dao TL
    J Natl Cancer Inst; 1975 Apr; 54(4):1007-9. PubMed ID: 805252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.